TLR7 agonist Imiquimod reduces the negative regulatory function of IL-10 transfected mouse bone marrow-derived dendritic cells
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To observe the effects of TLR7 agonist on the immune function of IL-10 transfected bone-marrow derived dendritic cell(mDC). Methods:The IL-10 plasmid was transfected to mouse mDC,and TLR7 agonist,Imiquimod,was added to mDC for 48 h. The expression of MHCⅡ,CD80,CD86,FasL in mDC were detected with flow cytometry,and the production of the IL-6 and TNF-α was detemined by ELISA. Results:IL-10 suppressed the expression of MHCⅡ,CD80,CD86,decreased the production of IL-6 and TNF-α,and increased the expression of FasL on mDC. Imiquimod increased the expression of MHCⅡ,CD80 and CD86,which enhanced the production of IL-6 and TNF-α,but inhibited of FasL expression by the IL-10 transfected mDC. Conclusion:TLR7 activation reverses IL-10 induced low response of mDC.

    Reference
    Related
    Cited by
Get Citation

Gong Li, Wang Yuanzhan, Lu Tao, Bai Xiaoyan, Zhu Yufeng, Wu Xianghui. TLR7 agonist Imiquimod reduces the negative regulatory function of IL-10 transfected mouse bone marrow-derived dendritic cells[J].,2015,(10):1360-1363.

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:December 01,2013
  • Revised:
  • Adopted:
  • Online: October 28,2015
  • Published:
Article QR Code